Tower Research Capital LLC (Trc) Cocrystal Pharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.27 - $3.6 $1,868 - $24,915	6,921 Added 26.87%	32,675 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.55 $6,588 - $9,536	17,339 Added 206.05%	25,754 $11,000
Q1 2022 May 12, 2022	BUY	$0.48 - $0.71 $4,039 - $5,974	8,415 New	8,415 $5,000
Q4 2020 Feb 16, 2021	SELL	$0.8 - $2.16 $9,036 - $24,397	-11,295 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.86 - $2.36 $2,276 - $6,246	2,647 Added 30.61%	11,295 $11,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $1.58 $6,053 - $13,663	8,648 New	8,648 $13,000
Q3 2019 Nov 05, 2019	SELL	$1.69 - $2.88 $169 - $288	-100 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.06 - $2.75 $2,912 - $3,888	-1,414 Reduced 93.39%	100 $0
Q1 2019 May 14, 2019	BUY	$2.65 - $4.14 $4,012 - $6,267	1,514 New	1,514 $4,000
Q4 2018 Feb 14, 2019	SELL	$1.6 - $3.68 $3,129 - $7,198	-1,956 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.3 - $4.95 $4,498 - $9,682	1,956 New	1,956 $5,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.9M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.